Status
Conditions
About
The goal of this observational multicenter case series is to assess the safety and performance of the CE-marked "Biphasic Plate Distal Femur" during standard of care.
Full description
The goal of this observational study is to assess the safety and performance of the CE-marked "Biphasic Plate Distal Femur" during standard of care. The study is conducted as a retrospective and prospective multicenter case series. Eligible patients are those with fractures of the distal femur who are treated with the Biphasic Plate DF according to the Instruction for Use (IFU). The patient will be followed-up until healing or up to 12 months, whichever comes first.
To assess the safety and performance following data is collected:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Patients with fractures of the distal femur requiring internal fixation and treated with the Biphasic Plate DF as indicated according to the IFU. As per the IFU, the Biphasic Plate DF is indicated for:
No other major implant beside the Biphasic Plate DF is used for fixation of the distal femur fracture, with the exceptions of lag screw(s) and/or cerclage wire(s), and/or a joint replacement.
Patients who are willing and able to comply with postoperative FUs per local standard of care.
Ability to provide informed consent according to the IRB/EC defined and approved procedures.
Patients over 18 years of age
Exclusion Criteria (preoperatively):
Exclusion Criteria (intraoperatively):
Loading...
Central trial contact
Marcel Aeschlimann; Ladina Hofmann
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal